Screener
Amgen AMGN Other, net
Other, net at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Extinguishment of debt | (233) | (602) |
| Repayment of debt | (833) | (3,500) |
| Dividends paid | (2,720) | (2,559) |
| Other | (224) | (119) |
| Net cash used in financing activities | (46) | (6,780) |
| Increase (decrease) in cash and cash equivalents | 4,860 | (3,945) |
| Cash and cash equivalents at beginning of period | 9,129 | 11,973 |
| Cash and cash equivalents at end of period | $13,989 | $8,028 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's other, net?
- Amgen (AMGN) reported other, net of -$120M in Q2 2026.
- How has Amgen's other, net changed year-over-year?
- Amgen's other, net decreased by 30.4% year-over-year, from -$92M to -$120M.
- What does other, net mean?
- Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.
Ask your AI about Amgen's other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude